GlaxoSmithKline logo

Corporate Executive Team

Simon Dingemans - Chief Financial Officer

Simon Dingemans

hi-res version (JPG) 576Kb


Simon became Chief Financial Officer in April 2011 after joining as Chief Financial Designate in January 2011. He is a member of the Board and the Corporate Executive Team.  Simon joined GSK from Goldman Sachs where he was a Managing Director and Partner. He has over 25 years experience in investment banking, including most recently as leader of Goldman Sachs’ European M&A business and before that as head of UK Investment Banking.

He joined Goldman Sachs in 1995, becoming Head of UK Investment Banking in 2000 and leader of Goldman Sachs’ European Mergers and Acquisitions business in 2007.  During this time, Simon had specific responsibility for many of the largest and most complex transactions that were carried out by Goldman Sachs in Europe, whilst continuing to have responsibility for a broad range of key UK client relationships, with a primary focus on large corporations.

Prior to joining the Company, Simon worked with GSK for over a decade and was closely involved in a number of GSK’s most important financial and strategic projects during that time, including, most recently, the establishment of ViiV Healthcare. His varied experience across a broad range of sectors during his time at Goldman Sachs has also resulted in direct experience of many of the different healthcare sectors and geographies currently served by GSK, including consumer as well as pharmaceutical markets.

After receiving a Masters degree in Geography from Oxford University in 1985, Simon joined S.G. Warburg Group, the investment banking firm which specialised in mergers and acquisitions, becoming one of its youngest directors in 1994.